Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

6.930 +0.340 (+5.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,226,525
Open 6.630
Bid (Size) 6.970 (9)
Ask (Size) 7.000 (7)
Prev. Close 6.590
Today's Range 6.560 - 7.130
52wk Range 5.605 - 77.65
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many... 
Via Benzinga
1 Growth Stock With 741% Upside, According to Wall Street
The vaccine maker has delivered returns of this size before, but things have changed a lot since. 
Via The Motley Fool

Performance

YTD
-29.21%
-29.21%
1 Month
N/A
N/A
3 Month
-29.21%
-29.21%
6 Month
-62.74%
-62.74%
1 Year
-90.68%
-90.68%

More News

Read More
Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze
Via InvestorPlace
3 Stocks That Won’t Survive a Major Market Crash
Via InvestorPlace
Why Novavax Stock Slipped on Thursday
Via The Motley Fool
1 Green Flag and 1 Red Flag for Novavax
Via The Motley Fool
This Growth Stock Is Down 90%. Is It Time to Sell or Buy?
Via The Motley Fool
1 Stock You Need to Sell Before the Next Bull Market
Via The Motley Fool
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via News Direct
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via TheNewswire.com
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via Benzinga
2 Growth Stocks That Are Trading at a Huge Discount Right Now -- Maybe Rightfully So
Via The Motley Fool
Why Is Novavax (NVAX) Stock Up 12% Today?
Via InvestorPlace
Why Novavax Stock Was Down in the Dumps This Week
Via The Motley Fool
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
Via InvestorPlace
Novavax Stock: Bear vs. Bull
Via The Motley Fool
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
Via The Motley Fool
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
Via Benzinga
US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony
Via Benzinga
Esperion Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Benzinga Bulls And Bears: Tesla, Microsoft, Apple, Novavax And Why Dogecoin May Be Poised For 50% Surge
Via Benzinga
Should You Give Up on Novavax?
Via The Motley Fool
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Nasdaq, S&P Futures Slide As Bond Yields Stay Above 4%: Economic Signals Ominous But Don't Panic Yet, Says Analyst
Via Benzinga
S&P 500 Drops For Second Session In A Row; Volatility In Markets Decreases
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.